Comparing two scope removal methods for small rectal neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This study compares two ways of removing very small rectal neuroendocrine tumors (less than 1 cm): a modified technique using a special snare (mDS-EMR) versus a more involved removal called ESD. Both are done through a scope (endoscopy) without major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a small rectal neuroendocrine tumor (less than 1 cm) that looks typical for this type of tumor on an endoscopic exam.
- The tumor is within 15 cm from the anal verge and appears to be confined to the inner layers of the rectum (mucosa and submucosa).
- You have no signs that the tumor has spread to other parts of the body.
- You do not have severe bleeding or clotting problems.
- You do not have any serious heart or blood vessel disease that would make the procedure unsafe.
- You have not had surgery for a neuroendocrine tumor in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This study is testing whether a minimally invasive endoscopic procedure (using a scope through the anus) can safely remove small rectal neuroendocrine tumors. If you're eligible, this could be a less invasive way to treat your condition without major surgery.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
This trial compares two minimally invasive ways to remove large, flat growths from the lower rectum — one done through a scope and one through a small surgical tool. The goal is to see which method is safer and more effective at removing the growth completely.
Hear when a new Rectal Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.